Who is sponsoring NCT06137820?

NCT06137820 is sponsored by Pharmanutra S.p.a..

What drugs are being tested in NCT06137820?

Interventions in NCT06137820: Cetilar® (topical cream), Cetilar Placebo.

What condition does NCT06137820 study?

NCT06137820 studies Ankle Injury or Chronic Trauma to the Ankle.

Is NCT06137820 still recruiting?

NCT06137820 is currently status unknown. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT06137820

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle

Status unknown NA Last updated 18 November 2023

What this trial tests

NA trial testing Cetilar® (topical cream) in Ankle Injury or Chronic Trauma to the Ankle in 80 participants. Status unknown.

Timeline

18 November 2022

Primary endpoint
19 August 2023

31 December 2023

Quick facts

Lead sponsor	Pharmanutra S.p.a.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	80
Start date	18 November 2022
Primary completion	19 August 2023
Estimated completion	31 December 2023
Sites	3 locations across Georgia, Italy

Drugs / interventions tested

Cetilar® (topical cream)
Cetilar Placebo

Conditions studied

Ankle Injury or Chronic Trauma to the Ankle — all drugs for Ankle Injury or Chronic Trauma to the Ankle →

Sponsor

Pharmanutra S.p.a. — full company profile →

Who can join

Adults 20 to 80, any sex, with Ankle Injury or Chronic Trauma to the Ankle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the safety, tolerability and efficacy of Cetilar®

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Pharmanutra S.p.a. trials

Trials by the same sponsor.

NCT06137833 — Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Che · NA · recruiting
NCT06134115 — LIKEST Study: Lipocet® in Adults With Primary Knee Osteoarthritis Grade 3-4 · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06137820 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pharmanutra S.p.a.
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06137820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing